[ad_1]
Stock Photography / INQUIRER.net
MANILA, Philippines – Belgium’s Janssen Pharmaceutical has already obtained approval from the Food and Drug Administration (FDA) to conduct phase 3 clinical trials in the country for its COVID-19 vaccine.
FDA Director General Eric Domingo made the announcement Tuesday, saying that Janssen will be the first to conduct clinical trials in the Philippines.
“’Yung natin’s clinical trial requests, we received three requests. We already approved one: ito po ‘yung Clinical Trial ng Janssen, ”Domingo said in an online media forum.
Applications from two other drug makers, Clover Biopharmaceuticals and Sinovac, are still under review, he added.
JPV
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our leaders in healthcare and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
